Trial Profile
Phase 2 Study of Efficacy and Safety of Trabectedin in Subjects With Advanced Ovarian Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary) ; Dexamethasone
- Indications Ovarian cancer
- Focus Therapeutic Use
- 21 Apr 2011 New trial record
- 21 Apr 2011 New trial record